Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure

PHASE4TerminatedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

March 31, 2013

Study Completion Date

June 30, 2013

Conditions
Heart Failure
Interventions
OTHER

Daxor Blood Volume Analysis

Radiolabeled albumin for direct measurement of blood volume

OTHER

Clinical volume status assessment

Volume assessment based on history and physical examination

Trial Locations (9)

10016

New York University Langone Medical Center, New York

10032

Columbia Presbyterian Medical Center, New York

18015

St. Luke's Regional Heart Center-Bethlehem, Bethlehem

19140

Temple University Hospital, Philadelphia

21201

Baltimore VA Medical Center, Baltimore

96813

Pacific Cardiology LLC, Honolulu

Unknown

Rush University Medical Center, Chicago

St. Thomas Research Institute, Nashvilled

07450

Valley Hospital, Ridgewood

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Daxor Corporation

INDUSTRY

lead

NYU Langone Health

OTHER